查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1405814

促智药市场规模、份额、趋势分析报告：依型态、配销通路、地区、细分市场预测，2023-2030

Nootropics Market Size, Share & Trends Analysis Report By Form (Capsules/ Tablets, Powder, Drinks), By Distribution Channel (Online, Offline), By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 90 Pages | 商品交期: 2-10个工作天内

价格

促智药市场成长与趋势：

Grand View Research, Inc.的最新报告显示，预计2030年全球促智药市场规模将达到111.7亿美元，2023年至2030年复合年增长率预计为14.6%。

全球市场在过去几年中不断增长，预计在预测期内将继续增长。这一增长是由于消费者对促智药对认知健康益处的认识不断提高以及消费者改善心理表现的愿望所推动的。随着世界人口高龄化，人们对支持大脑健康的产品越来越感兴趣，而促智药被认为是可行的选择。此外，压力和心理健康问题的普遍存在也鼓励人们探索认知增强剂。

促智胶囊很普及，因为它们易于服用，无需准备或混合。消费者只需用水吞服胶囊，这对生活忙碌的人来说是个方便的选择。胶囊提供精确且稳定量的促智成分。对于认知增强剂而言，这一点尤其重要，因为正确的剂量对于实现预期效果至关重要。胶囊是药物和营养补充的常见型态，可以提高促智食品的可信度。

由于消费者对这些产品的需求不断增长，促智药製造商越来越优先考虑天然成分。例如，2021年10月，促智能量饮料品牌XITE推出促智纯素蛋白棒，以吸引越来越多注重健康的消费者群。酒吧富含咖啡馆、L-茶氨酸和睡茄等益智药物，据说可以改善认知功能、注意力和能量水平。同样，2019 年 4 月，Gaia Herbs 推出了新的纯素补充品，名为 Bacopa（含过长沙）、Nootropic Focus（含藏红花、柠檬香脂和留兰香）以及 Agile Mind（含过长沙、银杏和姜黄）。

促智药市场报告亮点

  • 以型态，胶囊/锭剂促智药细分市场在 2022 年占据最大份额，达到 49.2%。胶囊和锭剂可以有效掩盖许多促智药的不良味道，使它们比粉状补充品更容易吞嚥。此外，封装和锭剂製程可防止成分暴露在空气和湿气中，从而延长成分的保质期，从而降低污染风险。
  • 就配销通路而言，预计2023年至2030年线上市场将以16.2%的复合年增长率成长。网路购物的便利性和普及性以及透过该管道提供的各种促智药是推动分销领域的主要因素。
  • 2022年，北美在全球市场中占据超过41.2%的主要份额。这是由于北美人们健康意识的不断增强以及对保持健康饮食和生活方式的兴趣日益浓厚。该地区对健康和预防性医疗保健的关注正在推动对促智药的需求。

目录

第一章调查方法与范围

第 2 章执行摘要

第三章促智市场变数、趋势和范围

  • 市场体系展望
  • 产业价值链分析
    • 销售/零售通路分析
    • 报酬率分析
  • 市场动态
    • 市场驱动因素分析
    • 市场抑制因素分析
    • 市场机会
    • 市场挑战
  • 产业分析-波特五力分析
  • 打入市场策略

第四章消费行为分析

  • 人口趋势分析
  • 消费者趋势和偏好
  • 影响购买决策的因素
  • 消费品采用
  • 主要观察结果和发现

第五章促智药市场：型态估计与趋势分析

  • 2022年和2030年型态变化分析和市场占有率
  • 胶囊/锭剂
    • 2017-2030 年市场估计与预测
  • 粉末
    • 2017-2030 年市场估计与预测
  • 喝
    • 2017-2030 年市场估计与预测
  • 其他的
    • 2017-2030 年市场估计与预测

第六章促智药市场：配销通路估计与趋势分析

  • 2022年及2030年配销通路波动分析及市场占有率
  • 离线
    • 2017-2030 年市场估计与预测
  • 在线的
    • 2017-2030 年市场估计与预测

第七章促智药市场：区域估计与趋势分析

  • 2022年和2030年区域变化分析和市场占有率
  • 北美洲
    • 2017-2030 年市场估计与预测
    • 按型态划分，2017-2030
    • 按配销通路划分，2017-2030
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 2017-2030 年市场估计与预测
    • 按型态划分，2017-2030
    • 按配销通路划分，2017-2030
    • 德国
    • 义大利
  • 亚太地区
    • 2017-2030 年市场估计与预测
    • 按型态划分，2017-2030
    • 按配销通路划分，2017-2030
    • 中国
    • 印度
  • 中美洲和南美洲
    • 2017-2030 年市场估计与预测
    • 按型态划分，2017-2030
    • 按配销通路划分，2017-2030
    • 巴西
  • 中东和非洲
    • 2017-2030 年市场估计与预测
    • 按型态划分，2017-2030
    • 按配销通路划分，2017-2030
    • 阿拉伯聯合大公国

第八章竞争分析

  • 主要市场参与企业的最新趋势和影响分析
  • 公司分类
  • 参与企业概况
  • 财务绩效
  • 产品基准评效
  • 2022年公司市场占有率分析（%）
  • 企业热力图分析
  • 策略规划
  • 本节分析的主要企业列表
    • Onnit Labs, Inc.
    • Reckitt Benckiser Group PLC
    • Mental Mojo, LLC
    • NooCube
    • Mind Lab Pro（Performance Lab Group Ltd）
    • TruBrain
    • Neu Mind, LLC
    • Nooflux LLC
    • Zhou Nutrition
    • Kimera Koffee
Product Code: GVR-4-68039-914-3

Nootropics Market Growth & Trends:

The global nootropics market size was estimated to reach USD 11.17 billion in 2030 and is expected to grow at a CAGR of 14.6% from 2023 to 2030, according to a new report by Grand View Research, Inc. The global market has witnessed increased growth in the last few years, which is expected to continue over the forecast period. This growth is driven by the increasing awareness among consumers regarding the cognitive health benefits of nootropics and their desire to improve mental performance. As the global population ages, there is a growing interest in products that support brain health, and nootropics are seen as a viable option. In addition, the prevalence of stress and mental health concerns is propelling individuals to explore cognitive enhancers.

Nootropic capsules have higher penetration as they are easy to take and do not require any preparation or mixing. Consumers can simply swallow a capsule with water, making it a convenient option for those with busy lifestyles. Capsules provide precise and consistent dosages of nootropic ingredients. This is particularly important when it comes to cognitive enhancers, as accurate dosing is crucial for achieving the desired effects. Capsules are a common form of pharmaceuticals and dietary supplements, which can enhance the perceived credibility of nootropic products.

Nootropics manufacturers are increasingly prioritizing natural ingredients in response to the growing consumer demand for such products. For instance, in October 2021, XITE, a nootropic energy drinks brand, launched a nootropic vegan protein bar to appeal to the growing consumer base of mind health-conscious consumers. The bars are packed with nootropics, such as caffeine, L-theanine, and ashwagandha, which are claimed to improve cognitive function, focus, and energy level. Similarly, in April 2019, Gaia Herbs launched new vegan supplements called Bacopa made using Bacopa; Nootropic Focus made with saffron, lemon balm, and spearmint; and Agile Mind made with Bacopa, gingko, and turmeric.

Nootropics Market Report Highlights:

  • Based on form, the capsule/ tablets nootropics segment held the largest share of 49.2% in 2022. Capsules and tablets effectively mask the unpleasant taste of many nootropics, making them easier to swallow compared to powdered supplements. In addition, the encapsulation or tableting process prolongs ingredients' shelf life by shielding them from exposure to air and moisture, reducing the risk of contamination
  • In terms of distribution channel, the online segment is anticipated to grow at a CAGR of 16.2% from 2023 to 2030. The convenience and popularity of online shopping and the availability of a wide variety of nootropics through this channel are key factors driving the distribution segment
  • North America held a major share of over 41.2% of the global market in 2022. This can be attributed to the rising trend of health consciousness among North Americans, leading to a heightened interest in maintaining a healthy diet and lifestyle. The region's focus on wellness and preventive healthcare drives the demand for nootropics

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1. Purchased Database
    • 1.3.2. GVR's Internal Database
    • 1.3.3. Secondary Products & Third-Party Perspectives
    • 1.3.4. Primary Research
  • 1.4. Information Analysis
    • 1.4.1. Data Analysis Models
  • 1.5. Market Formulation & Data Visualization
  • 1.6. Data Validation & Publishing

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Product Outlook
  • 2.3. Distribution Channel Outlook
  • 2.4. Regional Outlook

Chapter 3. Nootropics Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Industry Value Chain Analysis
    • 3.2.1. Sales/Retail Channel Analysis
    • 3.2.2. Profit Margin Analysis
  • 3.3. Market Dynamics
    • 3.3.1. Market Driver Analysis
    • 3.3.2. Market Restraint Analysis
    • 3.3.3. Market Opportunities
    • 3.3.4. Market Challenges
  • 3.4. Industry Analysis - Porter's Five Forces Analysis
  • 3.5. Market Entry Strategies

Chapter 4. Consumer Behavior Analysis

  • 4.1. Demographics Analysis
  • 4.2. Consumer Trends and Preferences
  • 4.3. Factors Affecting Buying Decision
  • 4.4. Consumer Product Adoption
  • 4.5. Key Observations & Findings

Chapter 5. Nootropics Market: Form Estimates & Trend Analysis

  • 5.1. Form Movement Analysis & Market Share, 2022 & 2030
  • 5.2. Capsules/Tablets
    • 5.2.1. Market estimates and forecast, 2017 - 2030 (USD Million)
  • 5.3. Powder
    • 5.3.1. Market estimates and forecast, 2017 - 2030 (USD Million)
  • 5.4. Drinks
    • 5.4.1. Market estimates and forecast, 2017 - 2030 (USD Million)
  • 5.5. Others
    • 5.5.1. Market estimates and forecast, 2017 - 2030 (USD Million)

Chapter 6. Nootropics Market: Distribution Channel Range Estimates & Trend Analysis

  • 6.1. Distribution Channel Movement Analysis & Market Share, 2022 & 2030
  • 6.2. Offline
    • 6.2.1. Market estimates and forecast, 2017 - 2030 (USD Million)
  • 6.3. Online
    • 6.3.1. Market estimates and forecast, 2017 - 2030 (USD Million)

Chapter 7. Nootropics Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Movement Analysis & Market Share, 2022 & 2030
  • 7.2. North America
    • 7.2.1. Market estimates and forecast, 2017 - 2030 (USD Million)
    • 7.2.2. Market estimates and forecast, by form, 2017 - 2030 (USD Million)
    • 7.2.3. Market estimates and forecast, by distribution channel, 2017 - 2030 (USD Million)
    • 7.2.4. U.S.
      • 7.2.4.1. Market estimates and forecast, 2017 - 2030 (USD Million)
      • 7.2.4.2. Market estimates and forecast, by form, 2017 - 2030 (USD Million)
      • 7.2.4.3. Market estimates and forecast, by distribution channel, 2017 - 2030 (USD Million)
    • 7.2.5. Canada
      • 7.2.5.1. Market estimates and forecast, 2017 - 2030 (USD Million)
      • 7.2.5.2. Market estimates and forecast, by form, 2017 - 2030 (USD Million)
      • 7.2.5.3. Market estimates and forecast, by distribution channel, 2017 - 2030 (USD Million)
    • 7.2.6. Mexico
      • 7.2.6.1. Market estimates and forecast, 2017 - 2030 (USD Million)
      • 7.2.6.2. Market estimates and forecast, by form, 2017 - 2030 (USD Million)
      • 7.2.6.3. Market estimates and forecast, by distribution channel, 2017 - 2030 (USD Million)
  • 7.3. Europe
    • 7.3.1. Market estimates and forecast, 2017 - 2030 (USD Million)
    • 7.3.2. Market estimates and forecast, by form, 2017 - 2030 (USD Million)
    • 7.3.3. Market estimates and forecast, by distribution channel, 2017 - 2030 (USD Million)
    • 7.3.4. Germany
      • 7.3.4.1. Market estimates and forecast, 2017 - 2030 (USD Million)
      • 7.3.4.2. Market estimates and forecast, by form, 2017 - 2030 (USD Million)
      • 7.3.4.3. Market estimates and forecast, by distribution channel, 2017 - 2030 (USD Million)
    • 7.3.5. Italy
      • 7.3.5.1. Market estimates and forecast, 2017 - 2030 (USD Million)
      • 7.3.5.2. Market estimates and forecast, by form, 2017 - 2030 (USD Million)
      • 7.3.5.3. Market estimates and forecast, by distribution channel, 2017 - 2030 (USD Million)
  • 7.4. Asia Pacific
    • 7.4.1. Market estimates and forecast, 2017 - 2030 (USD Million)
    • 7.4.2. Market estimates and forecast, by form, 2017 - 2030 (USD Million)
    • 7.4.3. Market estimates and forecast, by distribution channel, 2017 - 2030 (USD Million)
    • 7.4.4. China
      • 7.4.4.1. Market estimates and forecast, 2017 - 2030 (USD Million)
      • 7.4.4.2. Market estimates and forecast, by form, 2017 - 2030 (USD Million)
      • 7.4.4.3. Market estimates and forecast, by distribution channel, 2017 - 2030 (USD Million)
    • 7.4.5. India
      • 7.4.5.1. Market estimates and forecast, 2017 - 2030 (USD Million)
      • 7.4.5.2. Market estimates and forecast, by form, 2017 - 2030 (USD Million)
      • 7.4.5.3. Market estimates and forecast, by distribution channel, 2017 - 2030 (USD Million)
  • 7.5. Central & South America
    • 7.5.1. Market estimates and forecast, 2017 - 2030 (USD Million)
    • 7.5.2. Market estimates and forecast, by form, 2017 - 2030 (USD Million)
    • 7.5.3. Market estimates and forecast, by distribution channel, 2017 - 2030 (USD Million)
    • 7.5.4. Brazil
      • 7.5.4.1. Market estimates and forecast, 2017 - 2030 (USD Million)
      • 7.5.4.2. Market estimates and forecast, by form, 2017 - 2030 (USD Million)
      • 7.5.4.3. Market estimates and forecast, by distribution channel, 2017 - 2030 (USD Million)
  • 7.6. Middle East & Africa
    • 7.6.1. Market estimates and forecast, 2017 - 2030 (USD Million)
    • 7.6.2. Market estimates and forecast, by form, 2017 - 2030 (USD Million)
    • 7.6.3. Market estimates and forecast, by distribution channel, 2017 - 2030 (USD Million)
    • 7.6.4. UAE
      • 7.6.4.1. Market estimates and forecast, 2017 - 2030 (USD Million)
      • 7.6.4.2. Market estimates and forecast, by form, 2017 - 2030 (USD Million)
      • 7.6.4.3. Market estimates and forecast, by distribution channel, 2017 - 2030 (USD Million)

Chapter 8. Competitive Analysis

  • 8.1. Recent developments & impact analysis, by key market participants
  • 8.2. Company Categorization
  • 8.3. Participant's Overview
  • 8.4. Financial Performance
  • 8.5. Product Benchmarking
  • 8.6. Company Market Share Analysis, 2022 (%)
  • 8.7. Company Heat Map Analysis
  • 8.8. Strategy Mapping
  • 8.9. List of key companies analyzed in this section include:
    • 8.9.1. Onnit Labs, Inc. 
    • 8.9.2. Reckitt Benckiser Group PLC
    • 8.9.3. Mental Mojo, LLC
    • 8.9.4. NooCube
    • 8.9.5. Mind Lab Pro (Performance Lab Group Ltd)
    • 8.9.6. TruBrain
    • 8.9.7. Neu Mind, LLC
    • 8.9.8. Nooflux LLC
    • 8.9.9. Zhou Nutrition
    • 8.9.10. Kimera Koffee

List of Tables

  • Table 1 Nootropics market - Driving factor market analysis
  • Table 2 List of 14 nootropics that help enhance brain activity as well as performance
  • Table 3 Nootropics market- Restraint factor market analysis
  • Table 4 Nootropics market estimates & forecast, by form (USD Million)
  • Table 5 Nootropics market estimates & forecast, by distribution channel (USD Million)
  • Table 6 U.S. macro-economic outlay
  • Table 7 Canada macro-economic outlay
  • Table 8 Germany macro-economic outlay
  • Table 9 Italy macro-economic outlay
  • Table 10 China macro-economic outlay
  • Table 11 India macro-economic outlay
  • Table 12 Brazil macro-economic outlay
  • Table 13 South Africa macro-economic outlay
  • Table 14 Recent developments & impact analysis, by key market participants
  • Table 15 Company market share, 2022
  • Table 16 Company heat map analysis
  • Table 17 Key Companies launching new products
  • Table 18 Companies undergoing acquisitions
  • Table 19 Key Companies involved mergers and acquisitions  

List of Figures

  • Fig. 1 Nootropics market segmentation
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary research approaches
  • Fig. 5 Primary research process
  • Fig. 6 Market snapshot
  • Fig. 7 Form segment snapshot
  • Fig. 8 Distribution channel segment snapshot
  • Fig. 9 Competitive landscape Snapshot
  • Fig. 10 Global nootropics market size, 2017 to 2030 (USD Million)
  • Fig. 11 Global nootropics market - penetration & growth prospect mapping
  • Fig. 12 Nootropics market: Value chain analysis
  • Fig. 13 Nootropics market: Sales channel
  • Fig. 14 Nootropics market: Profit-margin analysis
  • Fig. 15 Nootropics market: Dynamics
  • Fig. 16 Global Nootropics Market Value; 2012, 2017 & 2022 (USD Million)
  • Fig. 17 Nootropics market: Porter's Five Forces analysis
  • Fig. 18 Roadmap of Nootropics Market
  • Fig. 19 Consumption nootropics. by age, 2022
  • Fig. 20 Consumption of supplements, by gender, 2022
  • Fig. 21 Spending on supplements, by income group, 2022
  • Fig. 22 Factors affecting buying decisions for nootropics
  • Fig. 23 Nootropics market, by form: Key takeaways
  • Fig. 24 Nootropics market, by form: Market share, 2022 & 2030
  • Fig. 25 Nootropics market estimates & forecasts, by capsules/ tablets, 2017 - 2030 (USD Million)
  • Fig. 26 Nootropics market estimates & forecasts, by powder, 2017 - 2030 (USD Million)
  • Fig. 27 Nootropics market estimates & forecasts, by drinks, 2017 - 2030 (USD Million)
  • Fig. 28 Nootropics market estimates & forecasts, by others, 2017 - 2030 (USD Million)
  • Fig. 29 Nootropics market, by distribution channel: Key takeaways
  • Fig. 30 Nootropics market, by distribution channel: Market share, 2022 & 2030
  • Fig. 31 Nootropics market estimates & forecasts through online channel, 2017 - 2030 (USD Million)
  • Fig. 32 Nootropics market estimates & forecasts through offline channel, 2017 - 2030 (USD Million)
  • Fig. 33 Nootropics market revenue, by region, 2022 & 2030, (USD Million)
  • Fig. 34 Regional marketplace: Key takeaways
  • Fig. 35 North America nootropics market estimates & forecast, 2017 - 2030 (USD Million)
  • Fig. 36 U.S. nootropics market estimates & forecast, 2017 - 2030 (USD Million)
  • Fig. 37 U.S. ADHD Insights, 2021
  • Fig. 38 Canada nootropics market estimates & forecast, 2017 - 2030 (USD Million)
  • Fig. 39 Europe nootropics market estimates & forecast, 2017 - 2030 (USD Million)
  • Fig. 40 Germany nootropics market estimates & forecast, 2017 - 2030 (USD Million)
  • Fig. 41 Italy nootropics market estimates & forecast, 2017 - 2030 (USD Million)
  • Fig. 42 Asia Pacific nootropics market estimates & forecast, 2017 - 2030 (USD Million)
  • Fig. 43 China nootropics market estimates & forecast, 2017 - 2030 (USD Million)
  • Fig. 44 India nootropics market estimates & forecast, 2017 - 2030 (USD Million)
  • Fig. 45 Central and South America nootropics market estimates & forecast, 2017 - 2030 (USD Million)
  • Fig. 46 Brazil nootropics market estimates & forecast, 2017 - 2030 (USD Million)
  • Fig. 47 Middle East & Africa nootropics market estimates & forecast, 2017 - 2030 (USD Million)
  • Fig. 48 UAE nootropics market estimates & forecast, 2017 - 2030 (USD Million)
  • Fig. 49 Company market share analysis, 2022
  • Fig. 50 Strategic framework of nootropics market